Characterization of genomic changes in the cervical pre-cancerous lesions and tumors induced by different types of human papillomaviruses

被引：2

作者：

Grozdanov P. ^{[1
]}

Hadjidekova S. ^{[2
]}

Dimova I. ^{[2
]}

Nikolova I. ^{[1
]}

Toncheva D. ^{[2
]}

Ganchev G. ^{[3
]}

Zlatkov V. ^{[4
]}

Galabov A.S. ^{[1
]}

机构：

[1] The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev, Sofia

[2] Department of Medical Genetics, Medical University, Sofia

[3] Specialized Hospital for Active Treatment in Oncology, Sofia

[4] The University Obstetrics and Gynecology Hospital “Maichin Dom”, Sofia

来源：

VirusDisease | 2016年 / 27卷 / 3期

关键词：

Cervical cancer; CNV; Genomic aberration; Human papillomavirus; Microarray CGH analysis;

D O I：

10.1007/s13337-016-0338-4

中图分类号：

学科分类号：

摘要：

Cervical carcinoma is the second most common malignancy among women in both incidence and mortality. Although much is known about the etiology and treatment of cervical cancer, the role of genetic alterations in the multistep pathway of cervical tumorigenesis is largely unknown. The aim of this study was to characterize the genomic changes in the cervical pre-cancerous lesions and tumors, induced by different types of human papillomaviruses. In this research was used the BlueGnome CytoChip oligo 2 × 105 K microarray for whole-genome oligo-array CGH. Microarray CGH analysis of 40 specimens was carried out—12 specimens from patients with early-stage squamous cell carcinomas; 19 specimens from patients with mild to moderate dysplasia and 9 with severe dysplasia. First we performed microarray CGH analysis of five DNA pools which contained the DNA from homogeneous groups of patients. The results revealed presence of micro chromosomal aberrations in chromosome region 14q11.2. According to the genome database these aberrations represent polymorphisms. Microarray analysis of DNA from 9 separate carcinoma lesions revealed a total of 26 aberrations in 14 chromosomes of nine patients. Our results showed the advantages of high-resolution chips in the clinical diagnosis of patients with cancerous and precancerous lesions caused by viral infection with HPV, but also highlight the need for extensive population studies revealing the molecular nature and clinical significance of different CNVs and the creation of detailed maps of variations in the Bulgarian population. This would facilitate extremely precise interpretation of specific genomic imbalances in the clinical aspect. © 2016, Indian Virological Society.

引用

页码：271 / 276

页数：5

共 25 条

[1]

Alvarado C.V., Micenmacher S., Ruiz Grecco M., Rubio M.F., Fernandez Larossa N., Costas M.A., RAC3 overexpression is a transforming and proliferative signal that contributes to tumoral development, Medicina (B), 71, 1, pp. 33-38, (2011)

[2]

Barbashina V., Salazar P., Holland E.C., Rosenblum M.K., Ladanyi M., Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene, Clin Cancer Res, 11, pp. 1119-1128, (2005)

[3]

Bieche I., Nogues C., Lidereau R., Overexpression of BRCA2 gene in sporadic breast tumours, Oncogene, 18, 37, pp. 5232-5238, (1999)

[4]

Di Vinci A., Infusini E., Peveri C., Sciutto A., Orecchia R., Geido E., Monaco R., Giaretti W., Intratumor heterogeneity of chromosome 1, 7, 17, and 18 aneusomies obtained by FISH and association with flow cytometric DNA index in human colorectal adenocarcinomas, Cytometry, 35, 4, pp. 369-375, (1999)

[5]

Duncan C.G., Killela P.J., Payne C.A., Lampson B., Chen W.C., Liu J., Solomon D., Waldman T., Towers A.J., Gregory S.G., McDonald R.E., Bigner D.D., Yan H., Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes, Oncotarget, 1, 4, pp. 265-277, (2010)

[6]

Espinosa J.M., Emerson B.M., Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment, Mol Cell, 8, pp. 57-69, (2010)

[7]

Haiman C.A., Patterson N., Freedman M.L., Myers S.R., Pike M.C., Waliszewska A., Neubauer J., Tandon A., Schirmer C., McDonald G.J., Greenway S.C., Stram D.O., Le Marchand L., Kolonel L., Frasco M., Wong D., Pooler L.C., Ardlie K., Oakley-Girvan I., Whittemore A.S., Cooney K.A., John E.M., Ingles S.A., Altshuler D., Henderson B.E., Reich D., Multiple regions within 8q24 independently affect risk for prostate cancer, Nat Genet, 39, pp. 638-644, (2007)

[8]

Hampton G.M., Penny A., Baergen R.N., Larson A., Brewer C., Birdii C.C., Stanbridge E.J., Evans G.A., Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-supressor gene to chromosome 11q22–q24, Proc Natd Acad Sci USA, 91, pp. 6953-6957, (1994)

[9]

Jung Y., Lee S., Choi H.S., Kim S.N., Lee E., Shin Y., Seo J., Kim B., Jung Y., Kim W.K., Chun H.K., Lee W.Y., Kim J., Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data, Clin Cancer Res, 17, 4, pp. 700-709, (2011)

[10]

Kersemaekers A.M.F., Hermans J., Fleuren G.J., van de Vijver M.J., Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix, Br J Cancer, 77, 2, pp. 192-200, (1998)

← 1 2 3 →